NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
54 hedge funds and large institutions have $16.4M invested in Niagen Bioscience, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 17 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
-1
Holders Change %
-1.82%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
17
Closed
5
Calls
$98K
Puts
$19K
Net Calls
+$79K
Net Calls Change
+$106K
Top Buyers
Top Sellers
1 |
TCM
Tieton Capital Management
Yakima,
Washington
|
-$173K |
2 |
Millennium Management
New York
|
-$73.5K |
3 |
D.E. Shaw & Co
New York
|
-$59.2K |
4 |
![]()
Simplex Trading
Chicago,
Illinois
|
-$45K |
5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$37K |